Α Multicenter Retrospective Study Evaluating Brivaracetam in the Treatment of Epilepsies in Clinical Practice

• Главные авторы: Maria Stefanatou (Автор), Eirini Vasileiadou Kapetanou (Автор), Vasilios K. Kimiskidis (Автор), Vasileios Papaliagkas (Автор), Panagiotis Polychronopoulos (Автор), Sofia Markoula (Автор), Kleoniki Charisiou (Автор), Dimitrios Kazis (Автор), Anastasia Verentzioti (Автор), Panayiotis Patrikelis (Автор), Athanasia Alexoudi (Автор), Stylianos Gatzonis (Автор)
• Формат: ‌
• Опубликовано: MDPI AG, 2021-02-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Brivaracetam (BRV) is the latest approved antiepileptic drug. The aim of the study was to evaluate the efficacy and tolerability of BRV in everyday clinical practice. In this retrospective, observational, multicenter study, data from epilepsy patients receiving BRV from January 2018 to July 2019 wer...